ADCYAP1 and Miyoshi myopathy: Based on the recommendations of the IMWG for the staging and risk classification of MM, endogenous PACAP-38 levels were examined according to the International Staging System (ISS), Revised International Staging System (R-ISS), and cytogenetic risk classification [30,31,32].